Abstract. The present study was conducted in an attempt to treat streptozotocin (STZ)-induced hyperglycemia by transplanting b cells derived from pancreatic ductal cells. Ductal cells obtained from neonatal rats were cultured in vitro. Approximately 70% of the cells were converted to insulin-secreting cells by incubating with betacellulin and activin A. Differentiated cells responded to a depolarizing concentration of potassium, tolbutamide and a high concentration of glucose, and insulin secretion increased by 2.5-, 2.3-and 1.6-fold, respectively. We then prepared pseudoislets using the differentiated cells, which exhibited greatly improved glucose-responsiveness, with a high concentration of glucose inducing a 3-fold increase in insulin secretion. We transplanted these pseudoislets into the portal vein of STZ-treated nude mice. Before transplantation, the plasma glucose concentration was above 400 mg/dl, and after transplantation it was markedly reduced, the effect of which persisted for two weeks. These results indicate that STZ-induced hyperglycemia can be treated by transplanting pseudoislets consisting of b cells derived from ductal cells. . This approach has an advantage in that transplanted islets are located in the upstream of the liver, a major target organ of insulin. The present study was conducted in an attempt to establish a method for b cell transplantation using cells derived from precursor cells located in the pancreatic duct. Our strategy was to induce differentiation of precursor cells in vitro and to prepare pseudoislets using insulin-secreting cells differentiated from the pancreatic ductal cells. The pseudoislets were then transplanted into the portal vein of the diabetic animals. The present results indicated that transplanted pseudoislets effectively improved hyperglycemia in streptozotocin (STZ)-treated mice.
PANCREATIC b cells are highly differentiated endocrine cells that secrete insulin, a principal hormone regulating glucose metabolism in the body. Reduction in the mass of functioning b cells impairs glucose metabolism and causes diabetes. Recent advances in cell biology have enabled researchers to induce differentiation of pancreatic precursor cells to b cells in a culture system [1] [2] [3] [4] . Insulin-producing cells have been obtained in vitro from precursor cells located in the pancreatic islets [2] and from epithelial cells in the pancreatic ducts [3, 4] . If a large number of b cells are obtained from those precursors in the culture system, diabetes mellitus can be treated by transplanting these functioning b cells. To achieve this therapeutic approach, several issues still remain to be resolved. First of all, a large number of functioning b cells are necessary to control glucose metabolism. Secondly, those b cells should have reasonably good insulin secretory response to ambient glucose and incretins. Thirdly, a method for effective transplantation should be established. In this regard, islets have been successfully transplanted into the portal vein in human islet transplantation [5] . This approach has an advantage in that transplanted islets are located in the upstream of the liver, a major target organ of insulin.
The present study was conducted in an attempt to establish a method for b cell transplantation using cells derived from precursor cells located in the pancreatic duct. Our strategy was to induce differentiation of precursor cells in vitro and to prepare pseudoislets using insulin-secreting cells differentiated from the pancreatic ductal cells. The pseudoislets were then transplanted into the portal vein of the diabetic animals. The present results indicated that transplanted pseudoislets effectively improved hyperglycemia in streptozotocin (STZ)-treated mice.
Experimental Procedure

Materials
Recombinant human activin A was generously provided by Dr. Y. Eto of the Central Research Laboratory, Ajinomoto Inc. (Kawasaki, Japan). Recombinant human BTC was prepared as described previously [6] . Fetal calf serum (FCS) was obtained from Gibco (Grand Island, NY, USA).
Cell culture
Pancreatic ducts were obtained from seven-day old male Wistar rats after collagenase digestion of the pancreas [7] . Ductal cells were dispersed by using Dispase (Godo Shuzo, Tokyo, Japan). Cells were then cultured in Dulbecco's modified Eagle's medium (DMEM) containing 2.7 mM glucose and 0.5% FCS, for two weeks. The medium was then changed to DMEM containing 25 mM glucose and 0.5% FCS and cultured for three weeks. To induce differentiation, duct epithelial cells were incubated with a combination of 2 nM activin A and 1 nM BTC for various periods.
Formation of pseudoislets
Ductal cells were incubated for five to seven days with 2 nM activin A and 1 nM BTC. Differentiated cells were then dispersed by trypsin digestion. To obtain pseudoislets, cell suspension (5 × 10 5 cells/ml) was incubated for 36 to 48 hrs in a gelatin-coated plastic dish with DMEM containing 1 nM BTC under constant stirring (30 rotations per min).
Measurement of mRNA expression
Total RNA was extracted by using TRIzol reagent (Invitrogen Japan, Tokyo, Japan). Messenger RNA was extracted using the Quick Prep Kit (Pharmacia LKB Biotechnology, Piscataway, NJ). Messenger RNA samples were pretreated with DNase to remove contamination of genomic DNA. First-strand cDNA was synthesized using a Preamplification System for SUPERSCRIPT First-Strand Synthesis System (Invitrogen Japan). To confirm no contamination of genomic DNA, samples without reverse transcription treatment were prepared. Primers used in this study were described elsewhere [8] . The reactions were conducted in a DNA Thermal Cycler (Perkin Elmer, Norwalk, CT) under the following conditions: denaturation at 94°C for 1 min, and annealing and extension at 65°C for 2 min. The number of cycles was 30, with the exception of 17 cycles for GAPDH. No PCR products were detected in the real-time PCR prodedure without reverse transcription.
Immunohistochemistry
For immunohistochemistry, cells were cultured on non-coated glass coverslips. Cells were fixed and immunostained with anti-insulin, anti-glucagon, antisomatostatin or anti-pancreatic polypeptide antibody as described previously [9, 10] . Images were obtained using a Zeiss microscope equipped with fluorescein and rhodamine filter sets (Axiophoto, Carl Zeiss, Thornwood, NY, USA).
Measurement of insulin
For measurement of insulin secretion, differentiated cells or pseudoislets were incubated for 60 min in Krebs-Ringer bicarbonate (KRB) buffer containing 0.1% bovine serum albumin. Samples were kept in -20°C until the assay. Insulin was measured by timeresolved immunofluorometric assay as described previously [9] .
Transplantation of pseudoislets
Four-week old nude mice were injected peritoneally with 150 mg/g STZ. On the next day (designated as day 0) pseudoislets were injected into the portal vein via the cecal vein and the morning plasma glucose concentration was measured daily by using AccuCheck Active (Roche Diagnostics GmbH, Germany). Statistical significance was determined by one-way ANOVA. Difference between the two groups was assessed by Student's t-test. Fig. 1C , cells incubated with activin A and BTC expressed mRNA for insulin, somatostatin and pancreatic polypeptide, but mRNA for glucagon was not detected. Similarly, mRNA for amylase was not expressed. Fig. 2 depicts the insulin secretory response of differentiated cells. These cells responded to a depoparizing concentration of potassium and tolbutamide, an inhibitor of the ATP-sensitive potassium (K ATP ) channel. A high concentration of glucose also induced a significant increase in insulin secretion although the response was modest (Fig. 2) . 
Results
Differentiation of ductal cells
Preparation of pseudoislets
We prepared pseudoislets using differentiated cells. Differentiated cells were cultured for 36 to 48 hr in a gelatin-coated dish. Fig. 3A shows the morphology of the pseudoislets. The diameter of pseudoislets was 160 ± 35 mm and the protein content was 1.01 ± 0.08 mg/pseudoislet (n = 5). Fig. 3B shows the insulin secretory response of the pseudoislets. As depicted, insulin secretory response in the pseudoislets was much improved compared to that of the cells cultured in monolayer. Thus, a high concentration of glucose induced more than a three-fold increase in insulin secretion.
Transplantation of pseudoislets
We then transplanted pseudoislets into the portal vein of the STZ-treated nude mice, introducing 50 pseudoislets per mouse. The changes in the plasma glucose concentration are shown in Fig. 4 . In STZtreated mice, the plasma glucose concentration was above 400 mg/dl. Indeed, transplantation of pseudoislets into the portal vein drastically reduced the plasma glucose concentration with the levels of plasma glucose remaining at about 200 mg/dl for at least two weeks.
Discussion
In the present study, we attempted to induce differentiation of ductal cells and convert them into insulinsecreting cells. Differentiation was achieved by the treatment with two differentiation factors, activin A Values are the mean ± S. E. for five experiments. *: p<0.05 vs control.
• ○ and BTC. A combination of these two factors was previously shown to convert amylase-secreting AR42J cells into insulin-producing cells [9] and intraislet precursor cells to b cells [2] . The majority of the differentiated cells expressed insulin, although some of them expressed somatostatin; interestingly, no cells expressed glucagon. Hence, a combination of these two factors may selectively induce differentiation to the b cell lineage. Differentiated cells possessed a regulatory secretion pathway since they were able to secrete insulin in response to a depolarizing concentration of potassium. They also responded to tolbutamide, an inhibitor of the K ATP channel. The latter observation suggests that differentiated cells also express the K ATP channel. More importantly, differentiated cells responded to a high concentration of glucose although the magnitude of the response was not great. Differentiated cells therefore express the machinery necessary for glucose-responsive insulin secretion including GLUT2, glucokinase, the K ATP channel and the voltage-dependent calcium channel. The insulin secretory response to glucose was much improved when differentiated cells formed pseudoislets. Thus, insulin response to high glucose concentration increased more than three-fold. The exact reason for the improved response is not clear, but cell adhesion and subsequent formation of gap junction may be among the causes. Islet b cells express E-cadherin [11] and, when adhered to each other, cells were electrically connected via gap junction. Presumably, b cells in pseudoislets do not simply form a cell cluster but also synchronize in terms of electrical activity as islet cells do [12] . In any case, the formation of pseudoislets is quite effective to obtain b cells with reasonably good secretory response. The formation of pseudoislets is also advantageous for transplantation into the portal vein. Although the exact location of the transplanted pseudoislets in the liver is not known, they certainly are located in the upstream of hepatocytes, a major target of the insulin action. As reported recently [13] , the liver has an envivonment supporting the differentiation and survival of pancreatic b cells, and in this sense transplantation into the portal vein is perhaps better than transplantation of islets in the peripheral tissue such as subcutaneous tissue.
In the present study, we established a method for transplantation of b cells obtained from precursor cells in the pancreatic duct. However, some issues remain to be resolved. First of all, a larger number of b cells in vitro need to be obtained for transplantation. We obtained approximately 50 pseudoislets using ductal cells obtained from three neonatal rats. If we could stimulate the proliferation of ductal cells more extensively or increase the number of insulin-producing cells during differentiation, more pseudoislets for transplantation could be used. In this regard, a different class of growth or differentiation factor is desirable. Also, better conditions for cultivation should be established. Secondly, although we could convert ductal cells to insulin-secreting b cells and obtained pseudoislets using the latter cells, maturation of the cells was still not high enough. The method for induction of differentiation needs to be improved. Again, a better differentiation factor would be effective to obtain more differentiated b cells. Also, culture conditions including extracellular matrix may be important. Thirdly, optimization of the conditions for transplantation is necessary. In particular, we really do not know yet how many pseudoislets are necessary to maintain normoglycemia for a long period. In human islet transplantation, the number of islets transplanted is a critical factor and a large number of islets provides a better outcome [5] . In this regard, the examination of the effect of transplantation using a greater number of pseudoislets is vital. Further studies are necessary to resolve these issues.
